GLG Inc’s GenMark Diagnostics, Inc GNMK Stock Holding History

GLG Inc’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-109,891	Closed	-$1.14M	–	770
2013 Q2	$1.14M	Buy	+109,891	New	+$1.52M	0.03%	420

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

GLG Inc's GNMK Position: Q3 2013 in Review

GLG Inc sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2013, closing a stake of 109,891 shares — an estimated $1.14M sold.

GLG Inc first reported a position in GNMK in Q2 2013 and held it in 1 quarter. The position peaked at $1.14M in Q2 2013. 73 funds tracked by Wall St. Rank hold GNMK as of Q3 2013.

GLG Inc reported no remaining GenMark Diagnostics, Inc position as of Q3 2013 after selling out during the quarter.
GLG Inc sold 109,891 GenMark Diagnostics, Inc shares in Q3 2013, an estimated $1.14M.
GLG Inc first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 1 quarter.
GLG Inc's GenMark Diagnostics, Inc position peaked at $1.14M in Q2 2013.
73 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2013.

Based on GLG Inc's 13F filing for Q3 2013, filed 14 Nov 2013.